Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, PlaceboControlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19
| dc.contributor.author | Cook, Paul P. | |
| dc.contributor.author | Jones, Rosie S. | |
| dc.date.accessioned | 2022-11-15T15:15:44Z | |
| dc.date.available | 2022-11-15T15:15:44Z | |
| dc.date.issued | 2022 | |
| dc.identifier.doi | 10.1177/11795484221119316 | |
| dc.identifier.issn | 1179-5484 | |
| dc.identifier.uri | http://hdl.handle.net/10342/11742 | |
| dc.language.iso | en_US | en_US |
| dc.subject | Acute respiratory distress syndrome | en_US |
| dc.subject | Angiopoietin 2 | en_US |
| dc.subject | COVID-19 | en_US |
| dc.title | Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, PlaceboControlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 | en_US |
| dc.type | Article | en_US |
| ecu.journal.name | Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | en_US |
| ecu.journal.volume | 16 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- CookEfficacyandSafetyofLY3127804.pdf
- Size:
- 798.09 KB
- Format:
- Adobe Portable Document Format
- Description: